Quest Diagnostics (DGX) Gains from Sales and Divestitures (2009 - 2011)

Quest Diagnostics has disclosed Gains from Sales and Divestitures across 3 years of filings, most recently posting $930000.0 for Q4 2011.

• Gains from Sales and Divestitures for Q4 2011 came in at $930000.0, up 25.34% year-over-year; the trailing twelve-month figure through Dec 2011 was $930000.0 (up 25.34% YoY), and the FY2011 annual result was $930000.0, up 25.34% from the prior year.
• Gains from Sales and Divestitures came in at $930000.0 for Q4 2011 at Quest Diagnostics, up from $742000.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $930000.0 in Q4 2011 to a low of $360000.0 in Q4 2009.
• The 3-year median for Gains from Sales and Divestitures is $742000.0 (2010), against an average of $677333.3.
• Across the five-year window, Gains from Sales and Divestitures jumped 106.11% in 2010 and climbed 25.34% in 2011, its largest moves.
• Quest Diagnostics' Gains from Sales and Divestitures stood at $360000.0 in 2009, then soared by 106.11% to $742000.0 in 2010, then gained by 25.34% to $930000.0 in 2011.
• The last three Gains from Sales and Divestitures figures came in at $930000.0 (Q4 2011), $742000.0 (Q4 2010), and $360000.0 (Q4 2009), per Business Quant data.